The aims of this thesis are to study strategies that may further improve patient outcome in hemophilia, by optimization of both patient care by interventions in adherence as well as treatment innovations.

This thesis consists of two parts. Part I will focus on strategies to further improve hemophilia patient care with regard to prophylactic home treatment and care in the outpatient clinic setting.

Part II of this thesis will focus on strategies to improve current dosing of factor concentrates.

F.W.G. Leebeek (Frank) , H.A. Moll (Henriƫtte) , M.H. Cnossen (Marjon)
Erasmus University Rotterdam
Printing of this thesis was kindly supported by: Bayer HealthCare, CSL Behring, Erasmus MC, Novo Nordisk, and Pfizer.
Department of Pediatrics

Lock, J. (2016, October 26). Optimization of care strategies in hemophilia. Retrieved from